silly to even discuss these things, its pure conjecture, but if just one licensing deal actually happens, that would enable cytodyn to grow into the the next merck, instead of simply getting absorbed by them and merck gets to reap all the benefits of the years of thankless hard work. even though current execs have stated that is not their desire. if its not their desire, then hire the people that desire that level of ambition to drive the bus, and those who are not interested can retire and move on to the exact role in life they are meant to pursue. if half of the indications that have been inferred as being possible come to any kind of fruition, an acquisition would be pure theft. i cant even think of a 3 fingered number that would justify its true value.
look up the history of keytruda pembrolizumab, its very relevant - strangely i remember the news in this era where the efforts to activated ones own immune system to fight disease was openly scoffed at as silly or impossible. the only way to treat, according to the establishment, is to carpet bomb with toxic substances. keytruda was an interesting accidental discovery at oganon (looking to develop a PD-1 agonist, and found the PD-1 antagonist), a company that was focused on fertility, contraception, and anesthesia. then organon was acquired a few years later by schering-plough in 2007, pembrolizumab being afterthought and no where near a primary IP for the acquisition, and before it could be explored further, schering-plough was acquired by merck in 2009. all pretty quick. keytruda got bounced around in the background for years. could have easily been permanently buried. it wasnt developed until bristol-myers squibb's PD-1 inhibitor (Opdivo) was making headlines and immunotherapy became the new buzzword that the executives knew they might have a similar drug and a bigtime winner. we all know now that keytruda has outsold all the other IP in all 3 of those companies combined. by a drug and a mechanism that was called snake oil, a scam, and nonsense by everybody except the true warriors.
this is amazing its an hour and worth every second. cant wait for the leronlimab version. -
https://podcasts.apple.com/us/podcast/keytrud...0767760619
leronlimab has had a similar brush with oblivion. such a waste in a very much flawed system. with a lot cocky of hot air. an acquisition potentially worth billions per year on just one of tens of very possible indications would be theft.
look up the history of keytruda pembrolizumab, its very relevant - strangely i remember the news in this era where the efforts to activated ones own immune system to fight disease was openly scoffed at as silly or impossible. the only way to treat, according to the establishment, is to carpet bomb with toxic substances. keytruda was an interesting accidental discovery at oganon (looking to develop a PD-1 agonist, and found the PD-1 antagonist), a company that was focused on fertility, contraception, and anesthesia. then organon was acquired a few years later by schering-plough in 2007, pembrolizumab being afterthought and no where near a primary IP for the acquisition, and before it could be explored further, schering-plough was acquired by merck in 2009. all pretty quick. keytruda got bounced around in the background for years. could have easily been permanently buried. it wasnt developed until bristol-myers squibb's PD-1 inhibitor (Opdivo) was making headlines and immunotherapy became the new buzzword that the executives knew they might have a similar drug and a bigtime winner. we all know now that keytruda has outsold all the other IP in all 3 of those companies combined. by a drug and a mechanism that was called snake oil, a scam, and nonsense by everybody except the true warriors.
this is amazing its an hour and worth every second. cant wait for the leronlimab version. -
https://podcasts.apple.com/us/podcast/keytrud...0767760619
leronlimab has had a similar brush with oblivion. such a waste in a very much flawed system. with a lot cocky of hot air. an acquisition potentially worth billions per year on just one of tens of very possible indications would be theft.
3
